Company profile: Genomic Vision
1.1 - Company Overview
Company description
- Provider of novel genetic tests and research tools for life sciences, developed and commercialized using Molecular Combing, a proprietary single DNA molecule detection technology, combined with biomarker discovery; focused on DNA analysis and genetic testing in cancer.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Genomic Vision
PamGene
HQ: The Netherlands
Website
- Description: Provider of kinase activity profiling and diagnostic solutions: IOpener diagnostic blood test measuring protein kinase activity to indicate likelihood of response to ICI therapy; PamChip microarray platform, PamStation instrument, and BioNavigator software; contract research for kinase inhibitor discovery and optimization; and ISO13485 compliant IVD assay services performing IOpener for melanoma and lung cancer patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PamGene company profile →
Chroma Medicine
HQ: United States
Website
- Description: Provider of genetic medicines built on an epigenetic editing platform that uses programmable editors to silence, activate, or regulate multiple genes by controlling chromatin conformation; single-dose genomic medicines for precise, predictable, durable treatment; multiplex epigenetic editing to enhance allogeneic CAR T cells; and a PCSK9-targeted editor to lower cholesterol and LDL-C.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chroma Medicine company profile →
Diagnoplex
HQ: Switzerland
Website
- Description: Provider of non-invasive colorectal cancer screening tests and diagnostics, including the COLOX colorectal cancer screening test; the company has conducted a 140-patient prospective pilot study demonstrating technical and clinical feasibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnoplex company profile →
Precision BioSciences
HQ: United States
Website
- Description: Provider of ARCUS genome editing technology using sequence-specific nucleases to modify DNA in living cells and tissues, a Manufacturing Center for Advanced Therapeutics for production of advanced therapies, PBGENE-HBV targeting chronic hepatitis B, and partnerships for in vivo gene editing and ex vivo CAR T-cell therapy development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Precision BioSciences company profile →
Biochrom
HQ: United Kingdom
Website
- Description: Provider of scientific instruments for clinical, life science, and industrial applications, including UV/Vis and compact spectrophotometers, microvolume spectrophotometers, colorimeters, amino acid analyzers and related chemicals, as well as microplate readers and washers, plus service contracts and preventive maintenance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biochrom company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Genomic Vision
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Genomic Vision
2.2 - Growth funds investing in similar companies to Genomic Vision
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Genomic Vision
4.2 - Public trading comparable groups for Genomic Vision
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →